Image 1 of 1
20110629_0001.jpg
BRUSSELS  -  BELGIUM  - 29 JUNE 2011 --  IF  and Bayer HealthCare Pharmaceuticals launch event of the report "Act against Europe's most common birth defects: one year on" at Radisson Blu EU Hotel. --(from left) Lars Joensson, Bayer HealthCare Pharmaceuticals; Stefan Staicu, Health Attaché at the Permanent Representation of Romania to the EU; Thomas Allvin, Health Attaché at the Permanent Representation of Sweden to the EU; Yann Le Cam, CEO European Organisation for Rare Diseases (EURORDIS); Dr. Denhard de Smit, Director projects and research - MediClara; Pierre Mertens,President of the International Federation for Spina Bifida and Hydrocephalus (IF) and Silke Mader, Chairwoman of the European Foundation for the Care of Newborn Infants (EFCNI). --  PHOTO: Juha ROININEN /  EUP-IMAGES